99 related articles for article (PubMed ID: 3320541)
1. Proliferation of AXC/SSh rat prostate cancer cells in vitro is androgen modulated.
Shain SA; Huot RI
J Steroid Biochem; 1987; 27(1-3):503-12. PubMed ID: 3320541
[TBL] [Abstract][Full Text] [Related]
2. Differential androgen modulation of AXC/SSh rat prostate cancer cell proliferation in vitro and its antagonism by antiandrogen.
Huot RI; Shain SA
Cancer Res; 1986 Aug; 46(8):3775-81. PubMed ID: 2942235
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and morphological characterization of clonal AXC rat prostate cancer cells.
Shain SA; Huot RI; Gorelic LS; Smith GC
Cancer Res; 1984 May; 44(5):2033-42. PubMed ID: 6713398
[TBL] [Abstract][Full Text] [Related]
4. Differential metabolism of dehydroepiandrosterone sulfate and estrogen conjugates by normal or malignant AXC/SSh rat prostate cells and effects of these steroid conjugates on cancer cell proliferation in vitro.
Huot RI; Shain SA
J Steroid Biochem; 1988 Jun; 29(6):617-21. PubMed ID: 2838688
[TBL] [Abstract][Full Text] [Related]
5. Differences in responsiveness of clonally derived AXC/SSh rat prostate cancer cells to secreted or prototypic mitogens.
Shain SA; Koger JD
Cancer Res; 1989 Jul; 49(14):3898-903. PubMed ID: 2786746
[TBL] [Abstract][Full Text] [Related]
6. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer.
Shain SA
Mol Urol; 2001; 5(3):121-30. PubMed ID: 11690559
[TBL] [Abstract][Full Text] [Related]
7. Antiandrogen effects in models of androgen responsive cancer.
Shain SA; Huot RI
J Steroid Biochem; 1988 Oct; 31(4B):711-8. PubMed ID: 3059063
[TBL] [Abstract][Full Text] [Related]
8. Androgen modulation of prostate cancer cell androgen receptor content is cell line specific.
Lin AL; Shain SA
Mol Cell Endocrinol; 1989 May; 63(1-2):75-83. PubMed ID: 2787764
[TBL] [Abstract][Full Text] [Related]
9. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin.
Yan G; Fukabori Y; Nikolaropoulos S; Wang F; McKeehan WL
Mol Endocrinol; 1992 Dec; 6(12):2123-8. PubMed ID: 1491693
[TBL] [Abstract][Full Text] [Related]
10. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a panel of rat ventral prostate epithelial cell lines immortalized in the presence or absence of androgens.
Rundlett SE; Gordon DA; Miesfeld RL
Exp Cell Res; 1992 Nov; 203(1):214-21. PubMed ID: 1330656
[TBL] [Abstract][Full Text] [Related]
12. AXC rat prostatic adenocarcinoma: characterization of cells in culture.
Shain SA; Boesel RW; Kalter SS; Heberling RL
Adv Exp Med Biol; 1981; 138():337-51. PubMed ID: 6282069
[TBL] [Abstract][Full Text] [Related]
13. Development of a prostate-specific promoter for gene therapy against androgen-independent prostate cancer.
Furuhata S; Ide H; Miura Y; Yoshida T; Aoki K
Mol Ther; 2003 Mar; 7(3):366-74. PubMed ID: 12668132
[TBL] [Abstract][Full Text] [Related]
14. Rat prostate cancer cells contain functional receptors for transforming growth factor-beta.
Shain SA; Lin AL; Koger JD; Karaganis AG
Endocrinology; 1990 Feb; 126(2):818-25. PubMed ID: 2153528
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4.
Wang MH; Abreu-Delgado Y; Young CY
Urology; 2003 Jul; 62(1):167-71. PubMed ID: 12837460
[TBL] [Abstract][Full Text] [Related]
16. Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer.
Kampa M; Theodoropoulou K; Mavromati F; Pelekanou V; Notas G; Lagoudaki ED; Nifli AP; Morel-Salmi C; Stathopoulos EN; Vercauteren J; Castanas E
J Pharmacol Exp Ther; 2011 Apr; 337(1):24-32. PubMed ID: 21205921
[TBL] [Abstract][Full Text] [Related]
17. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
[TBL] [Abstract][Full Text] [Related]
18. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
[TBL] [Abstract][Full Text] [Related]
19. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
Wu HC; Hsieh JT; Gleave ME; Brown NM; Pathak S; Chung LW
Int J Cancer; 1994 May; 57(3):406-12. PubMed ID: 8169003
[TBL] [Abstract][Full Text] [Related]
20. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
